Molecular genetic analysis of mycobacterium tuberculosis in the pandemic COVID-19

COVID-19 co-infection and tuberculosis are currently relevant in countries with a high tuberculosis burden. The article presents the results of a study of sensitivity to rifampicin in the context of the COVID-19 pandemic in both tuberculosis patients and patients with co-infection with COVID-19 and tuberculosis. Both in patients with tuberculosis and in patients with co-infection with Covid-19 and tuberculosis, sensitivity to rifampicin was observed more often than resistance. However, in co-infection with Covid-19 and tuberculosis, the percentage of resistance was much lower than in patients with tuberculosis.